VABESQ Trademark

Trademark Overview


On Tuesday, May 26, 2015, a trademark application was filed for VABESQ with the United States Patent and Trademark Office. The USPTO has given the VABESQ trademark a serial number of 79171207. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 19, 2019. This trademark is owned by Novartis AG. The VABESQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders and diabetes; antifungal, anti-...
vabesq

General Information


Serial Number79171207
Word MarkVABESQ
Filing DateTuesday, May 26, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 19, 2019
Registration Number4911653
Registration DateTuesday, March 8, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders and diabetes; antifungal, anti-infective and antiviral preparations and antibiotics
Translation of Words in MarkThe wording "VABESQ" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, September 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, November 19, 2020INTERNATIONAL REGISTRATION RENEWED
Friday, June 5, 2020NOTIFICATION PROCESSED BY IB
Friday, May 15, 2020NOTIFICATION PROCESSED BY IB
Friday, October 4, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 4, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, July 8, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 22, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 8, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 22, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 2, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 3, 2015ASSIGNED TO LIE
Wednesday, October 14, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 6, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 6, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 25, 2015REFUSAL PROCESSED BY IB
Thursday, September 10, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 10, 2015REFUSAL PROCESSED BY MPU
Thursday, September 10, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 9, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Wednesday, August 26, 2015APPLICATION FILING RECEIPT MAILED
Saturday, August 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 21, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 20, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB